Abstract
Background
For reasons that remain unclear, surgery for Graves’ disease is associated with a higher risk of hypocalcemia than surgery for benign atoxic goiter. In the present study, we evaluated risk factors for postoperative hypocalcemia in patients undergoing operation for Graves’ disease.
Methods
Data from 1,157 patients who underwent operation for Graves’ disease between 2004 and 2008 were extracted from the Scandinavian database for Thyroid and Parathyroid Surgery. Risk factors for postoperative hypocalcemia (in-hospital i. v. calcium; treatment with vitamin D analog at discharge, at 6 weeks, and at 6 months postoperatively) were evaluated by logistic regression analysis.
Results
Risk factors for i. v. calcium were low hospital volume of thyroid surgery (odds ratio [OR]: 95 % confidence interval [95 % CI], 0.99: 0.99–1.00), age (0.95: 0.91–1.00), operative time (1.02: 1.01–1.02), university hospital (12.91: 2.68–62.30), and reoperation for bleeding (10.32: 1.51–70.69).
The risk for treatment with vitamin D at discharge increased with operative time (1.01: 1.00–1.02), excised gland weight (1.01: 1.00–1.01), parathyroid autotransplantation (5.19: 2.28–11.84), and reoperation for bleeding (12.00: 2.43–59.28). At 6 weeks, vitamin D medication was associated with gland weight (1.00: 1.00–1.01), and preoperative medication with β-blockers (4.20: 1.67–10.55). At 6 months, vitamin D medication was associated with gland weight (1.00: 1.00–1.01) and reoperation for bleeding (10.59: 1.58–71.22).
Conclusions
Risk factors for medically treated hypocalcemia varied at different times of follow-up. Young age, operative time, type of hospital, and parathyroid autotransplantation were associated with early postoperatively hypocalcemia. Preoperative β-blocker treatment was a risk factor at the first follow-up. At early and late follow-up, gland weight and reoperation for bleeding were associated with medically treated hypocalcemia.
Similar content being viewed by others
References
Bergenfelz A, Jansson S, Kristoffersson A et al (2008) Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients. Langenbecks Arch Surg 393:667–673
Pesce CE, Shiue Z, Tsai H-L et al (2010) Postoperative hypocalcemia after thyroidectomy for Graves’ disease. Thyroid 20:1279–1283
Liu Q, Djuricin G, Prinz RA (1997) Total thyroid for benign thyroid disease. Surgery 123:2–7
Efremidou EI, Papageorgiou MS, Liratzopoulos N et al (2009) The efficacy and safety of total thyroidectomy in the management of benign thyroid disease: a review of 932 cases. Can J Surg 52:39–44
Thomusch O, Machens A, Sekulla C et al (2000) Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany. World J Surg 24:1141–1335. doi:10.1007/s002680010221
Weetman AP (2000) Review article. Graves’ disease. N Engl J Med 343:1236–1248
Järrhult J, Rudberg C, Larsson E et al (2005) Graves’ disease with moderate–severe endocrine ophthalmopathy—long term result of a prospective, randomized study of total or subtotal resection. Thyroid 15:1157–1164
Wilhelm S, McHenry CR (2010) Total thyroidectomy is superior to subtotal thyroidectomy for management of Graves’ disease in the United States. World J Surg 34:1261–1264. doi:10.1007/s00268-009-0337-3
Witte J, Goretzki PE, Dotzenrath C et al (2000) Surgery for Graves’ disease: total versus subtotal thyroidectomy—results of a prospective randomized trial. World J Surg 24:1303–1311. doi:10.1007/s002680010216
Boostrom S, Richards ML (2007) Total thyroidectomy is the preferred treatment for patients with Graves’ disease and thyroid nodule. Otolaryngol Head Neck Surg 136:278–281
Vaiman M, Nagibin A, Olevson J (2010) Complications in primary and completed thyroidectomy. Surg Today 40:114–118
Hassan I, Danila R, Maurer E et al (2008) Severe Graves’ ophthalmopathy may be a risk factor for the development of postthyroidectomy hypocalcaemia. Exp Clin Endocrinol Diabetes 116:614–618
Moriyama T, Yamashita H, Noguchi S et al (2005) Intraoperative parathyroid hormone assay in patients with Graves’ disease for prediction of postoperative tetany. World J Surg 29:1282–1287. doi:10.1007/s00268-005-7880-3
Karakas E, Osei-Agyemang T, Schlosser K et al (2008) The impact of parathyroid gland autotransplantation during bilateral thyroid surgery for Graves’ disease on postoperative hypocalcaemia. Endocr Regul 42:39–44
Barakate MS, Agarwal G, Reeve TS et al (2002) Total thyroidectomy is now the preferred option for the surgical management of Graves’ disease. Aust N Z J Surg 72:321–324
Yamashita H, Noguchi S, Tahara K et al (1997) Postoperative tetany in patients with Graves’ disease: a risk factor analysis. Clin Endocrinol 47:71–77
Greenland S, Neutra R (1980) Control of confounding in the assessment of medical technology. Int J Epidemiol 9:361–367
Thomusch O, Machens A, Sekulla C et al (2002) The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: a multivariate analysis of 5,846 consecutive patients. Surgery 133:180–185
Scandinavian Quality Register for Thyroid and Parathyroid Surgery (2010) Annual Report 2009, Lund. ISBN:978-91-978553-2-7
Toniato A, Bosuchin IM, Piotta A et al (2008) Thyroidectomy and parathyroid hormone: tracing hypocalcemia-prone patients. Am J Surg 196:285–288
Cavicchi O, Piccin O, Caliceti U et al (2007) Transient hypoparathyroidism following thyroidectomy: a prospective study and multivariate analysis of 604 consecutive patients. Otolaryngol Head Neck Surg 137:654–658
Sitga-Serra A, Ruiz S, Girvent M et al (2010) Outcome of protracted hypoparathyroidism after total thyroidectomy. Br J Surg 97:1687–1695
Sosa JA, Bowman HM, Tielsch JM et al (1998) The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 228:320–330
Stavrakis AI, Ituarte P, Ko CY et al (2007) Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery. Surgery 142:887–899
Erbil Y, Barbaros U, Temel B et al (2009) The impact of age, vitamin D level, and incidental parathyroidectomy on postoperative hypocalcemia after total thyroidectomy or near total thyroidectomy. Am J Surg 197:439–446
Hermann M, Ott J, Promberger R et al (2008) Kinetics of serum parathyroid hormone during and after thyroid surgery. Br J Surg 95:1480–1487
Testini M, Rosato L, Avenia N et al (2007) The impact of single parathyroid gland autotransplantation during thyroid surgery on postoperative hypoparathyroidism: a multicenter study. Transplant Proc 39:225–230
El-Sharaky MI, Kahalil MR, Sharaky O et al (2003) Assessment of parathyroid autotransplantation for preservation of parathyroid function after total thyroidectomy. Head Neck 25:799–807
Kukreja SC, Hargis GK, Bowser EN et al (1975) Role of adrenergic stimuli in parathyroid hormone secretion in man. J Clin Endocrinol Metab 40:478–481
Jung A, Mayer P, Hurst G et al (1982) Parathyroid gland response to epinephrine: a rate-sensitivity mechanism. Am J Physiol 242:151–156
Acknowledgments
This work was supported by grants from the Swedish Local Authorities and Regions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hallgrimsson, P., Nordenström, E., Almquist, M. et al. Risk Factors for Medically Treated Hypocalcemia after Surgery for Graves’ Disease: A Swedish Multicenter Study of 1,157 Patients. World J Surg 36, 1933–1942 (2012). https://doi.org/10.1007/s00268-012-1574-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-012-1574-4